Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 17418 matches for

Do you want to know more about Open Access? Find out about Act on Acceptance & ORCID from an expert? Book a place for our session on Tuesday 23rd August, 2-3pm in Room B at the WTCHG. Juliet Ralph, the Open Access Subject librarian, will be available for your toughest questions.

CTMGH logo for News

OUCRU Covid-19 portfolio (updated Feb 2022) text only

Accessible version, with text only, of the OUCRU portfolio that provides an overview of all the on-going projects that our entire programme have been working on to contribute to the understanding and management of COVID-19 and its national, regional and global impact.

OUCRU - COVID-19 Portfolio 2021 (Updated February 2022) (Text-only).pdf (1 MB)

OUCRU Covid-19 portfolio (updated Feb 2022)

This portfolio provides an overview of all the on-going projects that our entire programme have been working on to contribute to the understanding and management of COVID-19 and its national, regional and global impact.

OUCRU - COVID-19 Portfolio 2021 (Updated February 2022).pdf (2 MB)

OCGHR Marketing leaflet

Two-page summary of research activities within OCGHR

OCGHR Marketing leaflet master.pdf (681 KB)

OCGHR Building a Global Health Community brochure

Brochure describing the Oxford Centre for Global Health Research. This file contains minor issues with images and reading order, and we apologies for this. An accessible version (without images) can be found at https://www.tropicalmedicine.ox.ac.uk/files/ocghr-files/building-a-global-health-community.pdf

OCGHR brochure Master 6.pdf (1 MB)

Accessible OCGHR Building a Global Health Community brochure

Accessible version (no images and no issue with reading order) of the OCGHR Building a Global Health Community brochure

Building a global health community.pdf (187 KB)

OCGHR Themes brochure

Brochure describing the various themes underlying research at OCGHR: Better data and evidence, Innovation and implementation, Sharing knowledge and strengthening capacity, Enhancing policy and practice, Strengthening healh and research systems

3444 OCGHR Themes MM v16 master.pdf (3 MB)

Sir David Weatherall, 1933-2018

Sir David’s recollections of how MORU came about - this old PDF was checked and made more accessible, as much as we could. We apologise for the inconvenience

Sir_David_Weatherall_early_days_MORU-converted-for-accessibility.pdf (1 MB)

Picturing health dengue Dec19

GIF file of photos by Pearl Gan: (1) two gloved hands manipulating a mosquito in a petri dish. (2 & 3) Doctor checking a child's forearm in a health facility. (4) Young Vietnamese girl sitting and eating

Picturing-Health-Dengue.gif (859 KB)

NDM video coming soon

This short video of 5 seconds is a holding file, with the text 'NDM podcast Coming soon'

Coming-soon.mp4 (388 KB)

MSc Scholarships February 2021

This excel spreadsheet contains information about various scholarships available to MSc students - last updated in February 2021

MSc-Scholarships-2021-February.xlsx (38 KB)

Rogier van Doorn AMR surveillance data October 2020

Slide of Rogier van Doorn presentation for TropMed webinar on AMR surveillance, October 2020

20201013 Oxford webinar Rogier.pdf (1 MB)

Paul Turner AMR surveillance in LMICs October 2020

PDF slides of Paul Turner from our COMRU unit in Cambodia telling us about the pressing need for quality laboratory data in low and middle income countries, for better antimicrobial resistance surveillance. TropMed webinar on AMR surveillance, October 2020

20201013_Turner_AMR_surveillance_data.pdf (2 MB)

Similar stories

RECOVERY trial team members appointed MBEs

Two RECOVERY Trial team members have been recognised in the New Year Honours list 2022. RECOVERY Trial coordinator, Professor Richard Haynes, has been appointed Member of the Order of the British Empire (MBE) for services to Global Health, and Senior Clinical Trial Manager, Lucy Fletcher, has been appointed MBE for services to Clinical Trials. The New Year Honours list recognises outstanding achievements by a wide range of extraordinary people from across the United Kingdom. People are awarded honours for achievements in their field of work (including health, education, science and technology), as well as for making a difference to their community.

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include OUCRU in Vietnam and institutions in Canada, Chile, Australia and the UK. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Oxford retains top spot in world rankings for sixth consecutive year

The University of Oxford remains top of the table in latest Times Higher Education World University Rankings. In a year dominated by the ongoing Covid-19 pandemic, the rankings reflect the vital role of universities in understanding and managing the crisis as a number of institutions around the world saw significant boosts in their citation scores from Covid-19 focused research.

OUCRU scientists identify combination of biological markers associated with severe dengue

Nguyen Lam Vuong, Sophie Yacoub & colleagues have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease. Biomarkers are used to identify the state or risk of a disease in patients; these findings could aid the development of biomarker panels for clinical use and help improve triage and risk prediction in patients with dengue.

RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19. Patients with COVID-19 are at increased risk of blood clots forming in their blood vessels, particularly in the lungs. Between November 2020 and March 2021, the RECOVERY trial included nearly 15,000 patients hospitalised with COVID-19 in an assessment of the effects of aspirin, which is widely used to reduce blood clotting in other diseases. There was no significant difference in the primary endpoint of 28-day mortality